Your browser doesn't support javascript.
loading
Characterization of arrhythmia substrate to ablate persistent atrial fibrillation (COAST-AF): Randomized controlled trial design and rationale.
Nery, Pablo B; Wells, George A; Verma, Atul; Joza, Jacqueline; Nair, Girish M; Veenhuyzen, George; Andrade, Jason; Nault, Isabelle; Wong, Jorge A; Sikkel, Markus; Essebag, Vidal; Macle, Laurent; Sapp, John; Roux, Jean-Francois; Skanes, Allan; Angaran, Paul; Novak, Paul; Redfearn, Damian; Golian, Mehrdad; Redpath, Calum J; Sturmer, Marcio; Birnie, David.
Afiliación
  • Nery PB; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.. Electronic address: PNery@ottawaheart.ca.
  • Wells GA; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.; Cardiovascular Research Methods Center, University of Ottawa Heart Institute, Ottawa, Canada.
  • Verma A; McGill University Health Center, Montreal, Quebec, Canada.
  • Joza J; McGill University Health Center, Montreal, Quebec, Canada.
  • Nair GM; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.
  • Veenhuyzen G; Libin Cardiovascular Institute, University of Calgary, Calgary, Canada.
  • Andrade J; Vancouver General Hospital, University of British Columbia,Vancouver, Canada.
  • Nault I; Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ), Quebec City, Quebec, Canada.
  • Wong JA; Hamilton Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Sikkel M; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada.
  • Essebag V; McGill University Health Center, Montreal, Quebec, Canada; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada.
  • Macle L; Montreal Heart Institute, Montreal, Québec, Canada.
  • Sapp J; Queen Elizabeth II Health Sciences, Halifax, Nova Scotia, Canada.
  • Roux JF; CHUS-Sherbrooke, Sherbrooke, Quebec, Canada.
  • Skanes A; Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
  • Angaran P; St. Michael's Hospital, University of Toronto, Toronto, Ontario, Canada.
  • Novak P; Victoria Cardiac Arrhythmia Trials, Victoria, British Columbia, Canada.
  • Redfearn D; Kingston General Hospital, Kingston, Ontario, Canada.
  • Golian M; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.
  • Redpath CJ; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.
  • Sturmer M; Hôpital Sacré-Cœur, Université de Montréal, Montréal, Québec, Canada.
  • Birnie D; Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Canada.
Am Heart J ; 254: 133-140, 2022 Dec.
Article en En | MEDLINE | ID: mdl-36030965
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Ablación por Catéter Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Venas Pulmonares / Fibrilación Atrial / Ablación por Catéter Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Am Heart J Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos